Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia, Proceedings of the National Academy of Sciences, vol.55, issue.16, pp.3132-3136, 1999. ,
DOI : 10.1111/j.1651-2227.1970.tb08986.x
Recent advances in the bcr-abl negative chronic myeloproliferative diseases, Journal of Translational Medicine, vol.4, issue.1, p.41, 2006. ,
DOI : 10.1186/1479-5876-4-41
Different mutations of the human c-mpl gene indicate distinct haematopoietic diseases, Journal of Hematology & Oncology, vol.6, issue.1, p.11, 2013. ,
DOI : 10.1007/s12185-009-0413-3
Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia, British Journal of Haematology, vol.35, issue.6, pp.808-813, 2008. ,
DOI : 10.1073/pnas.96.14.8126
Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia, Growth Factors, vol.315, issue.1, pp.18-26, 2014. ,
DOI : 10.1006/jmbi.2001.5243
The thrombopoietin receptor P106L mutation functionally separates receptor signaling activity from thrombopoietin homeostasis, Blood, vol.125, issue.7, pp.1159-1169, 2015. ,
DOI : 10.1182/blood-2014-07-587170
URL : http://www.bloodjournal.org/content/bloodjournal/125/7/1159.full.pdf
Mpl Baltimore: A thrombopoietin receptor polymorphism associated with thrombocytosis, Proceedings of the National Academy of Sciences, vol.93, issue.2, pp.11444-11447, 2004. ,
DOI : 10.1073/pnas.0401496101
URL : http://www.pnas.org/content/101/31/11444.full.pdf
Calreticulin-mutant proteins induce megakaryocytic signaling to transform hematopoietic cells and undergo accelerated degradation and Golgi-mediated secretion, Journal of Hematology & Oncology, vol.59, issue.Pt 5, p.45, 2016. ,
DOI : 10.1016/0092-8674(89)90019-6
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894373
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants, Blood, vol.127, issue.10, pp.1325-1335, 2016. ,
DOI : 10.1182/blood-2015-11-681932
URL : http://www.bloodjournal.org/content/bloodjournal/127/10/1325.full.pdf
Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation, Proceedings of the National Academy of Sciences, vol.14, issue.1, pp.18962-18967, 2005. ,
DOI : 10.1093/protein/14.1.27
Surface expression of Mpl: aberrant Mpl trafficking in myeloproliferafive neoplasms is linked to insufficient expression of wild type Jak2, Blood, vol.118, issue.21, 2011. ,
The Membrane-proximal Region of the Thrombopoietin Receptor Confers Its High Surface Expression by JAK2-dependent and -independent Mechanisms, Journal of Biological Chemistry, vol.266, issue.50, pp.38930-38940, 2006. ,
DOI : 10.1042/0264-6021:3610105
Mpl Traffics to the Cell Surface Through Conventional and Unconventional Routes, Traffic, vol.19, issue.9, pp.961-982, 2014. ,
DOI : 10.1093/emboj/19.21.5720
URL : http://onlinelibrary.wiley.com/doi/10.1111/tra.12185/pdf
MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease, Human Mutation, vol.27, issue.3, p.296, 2006. ,
DOI : 10.1002/humu.9415
Congenital Amegakaryocytic Thrombocytopenia: Clinical Presentation, Diagnosis, and Treatment, Seminars in Thrombosis and Hemostasis, vol.37, issue.06, pp.673-681, 2011. ,
DOI : 10.1055/s-0031-1291377
Durable engraftment and correction of hematological abnormalities in children with congenital amegakaryocytic thrombocytopenia following myeloablative umbilical cord blood transplantation, Pediatric Transplantation, vol.21, issue.7, pp.753-757, 2015. ,
DOI : 10.1038/sj.bmt.1701147
The Rise of CRISPR/Cas for Genome Editing in Stem Cells, Stem Cells International, vol.16, issue.11, p.8140168, 2016. ,
DOI : 10.1073/pnas.1314697110
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells, Science Translational Medicine, vol.12, issue.12, pp.360-134, 2016. ,
DOI : 10.1186/1471-2105-12-323
A standardized endogenous megakaryocytic erythroid colony assay for the diagnosis of essential thrombocythemia, Haematologica, vol.89, issue.10, pp.1207-1212, 2004. ,
Identification of the Residues in the Extracellular Domain of Thrombopoietin Receptor Involved in the Binding of Thrombopoietin and a Nuclear Distribution Protein (Human NUDC), Journal of Biological Chemistry, vol.14, issue.34, pp.26697-26709, 2010. ,
DOI : 10.1084/jem.185.11.1939
Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO, Blood, vol.87, issue.11, pp.4552-4560, 1996. ,
Secretory autophagy, Current Opinion in Cell Biology, vol.35, pp.106-116, 2015. ,
DOI : 10.1016/j.ceb.2015.04.016
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529791
Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA, Nature Biotechnology, vol.69, issue.3, pp.339-344, 2016. ,
DOI : 10.1016/B978-0-12-801185-0.00001-5
CRISPR/Cas9 systems targeting ??-globin and CCR5 genes have substantial off-target activity, Nucleic Acids Research, vol.41, issue.20, pp.9584-9592, 2013. ,
DOI : 10.1093/nar/gkt714
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814385
Congenital Amegakaryocytic Thrombocytopenia: A Brief Review of the Literature, Clinical Medicine Insights: Pathology, vol.3, pp.25-30, 2010. ,
DOI : 10.4137/CPath.S4972
The mutational burdens and evolutionary ages of early gastric cancers are comparable to those of advanced gastric cancers, The Journal of Pathology, vol.4, issue.3, pp.365-374, 2014. ,
DOI : 10.1038/nrc1360
Rescue of ??F508-CFTR Trafficking via a GRASP-Dependent Unconventional Secretion Pathway, Cell, vol.146, issue.5, pp.746-760, 2011. ,
DOI : 10.1016/j.cell.2011.07.021
Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potential, Nature Communications, vol.8, p.8620, 2015. ,
DOI : 10.1042/bj3570759
DNA targeting specificity of RNA-guided Cas9 nucleases, Nature Biotechnology, vol.49, issue.9, pp.827-832, 2013. ,
DOI : 10.1073/pnas.1019533108
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969858
Use of genome-editing tools to treat sickle cell disease, Human Genetics, vol.118, issue.6, pp.1011-1028, 2016. ,
DOI : 10.1182/blood-2011-02-335554